Cwa Asset Management Group, LLC Gilead Sciences, Inc. Transaction History
Cwa Asset Management Group, LLC
- $1.85 Billion
- Q3 2024
A detailed history of Cwa Asset Management Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 75,770 shares of GILD stock, worth $6.92 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
75,770
Previous 22,716
233.55%
Holding current value
$6.92 Million
Previous $1.66 Million
281.9%
% of portfolio
0.34%
Previous 0.1%
Shares
29 transactions
Others Institutions Holding GILD
# of Institutions
1,927Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.5 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.99 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.65 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.5 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $114B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...